Why the study?
To compare the long-term results of thoracoscopic ablation versus ablation index-guided catheter ablation in patients with non-paroxysmal AF.
Does thoracoscopic ablation with left atrial appendage exclusion improve effectiveness compared to catheter ablation using the ablation index in patients with non-paroxysmal atrial fibrillation?
Does thoracoscopic ablation with left atrial appendage exclusion improve effectiveness compared to catheter ablation using the ablation index in patients with non-paroxysmal atrial fibrillation?
Thoracoscopic ablation and ablation index-guided catheter ablation show comparable overall efficacy and safety at 12 months for non-paroxysmal AF, though thoracoscopic ablation may provide greater freedom from AF at 6 months.
Comparable 12-month efficacy and safety in this cohort; leaves open whether thoracoscopic ablation improves outcomes in non-paroxysmal AF.
Aim. To conduct a comparative assessment of the long-term results of thoracoscopic and catheter ablation using the ablation index in patients with non-paroxysmal atrial fibrillation (AF). Methods. A comparative analysis of the long-term results of catheter ablation using the ablation index - group № 1 (36 patients) and thoracoscopic ablation with the left atrial appendage exclusion - group № 2 (42 patients) was performed. Results. The effectiveness of catheter ablation was 57.14%, thoracoscopic ablation - 67.5% at 12-month followup (р=0,128). There were also no statistically significant differences in safety (p=0.55). Analyzing the structure of postprocedural atrial tachycardias in group №1 was demonstrated that AF recurrence was in 93.3%, in group №2 - in 50%. Atypical atrial flutter was documented in 6.6% of cases in group №1 and in 31.5% - in group №2. Typical atrial flutter was documented only in group №2 (18.75% (3)). However, AF recurrence was more common in the catheter ablation group after 6 months of follow-up (p=0.04). Conclusion. Catheter and thoracoscopic ablation are comparable in terms of overall efficacy and safety, however, thoracoscopic ablation provides greater freedom from AF in a 6 month.
No takes yet. Share an insight, caveat, or question.
Taymasova et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: